NEW YORK, Sept. 3-Amersham Biosciences has licensed a set of protein capture-related patents from UpFront Chromatography, the company said today.
The patents cover expanded bed adsorption techniques, a streamlined method of capturing proteins from crude biological samples. Amersham plans to use UpFront's EBA technology to improve its Streamline protein separation platform.
As part of this agreement, UpFront Chromatography will receive non-exclusive rights to Amersham's own EBA patents.
UpFront Chromatography, which develops protein chemistry and chromatographic adsorption techniques, is based in Copenhagen, Denmark.